Allarity Therapeutics and Lantern Pharma Enter into Agreement for Future Clinical Development of Irofulven Lantern will reacquire global rights to Irofulven and assume full authority to manage and guide future clinical and commercial development of the program Press release Hørsholm, Denmark and...